Squarepoint Ops LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 142 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q3 2023$4,385,665
+208.4%
84,194
+220.6%
0.01%
+83.3%
Q1 2023$1,421,979
+75.6%
26,260
+50.8%
0.01%
+50.0%
Q3 2022$810,000
+166.4%
17,410
+199.4%
0.00%
+300.0%
Q4 2021$304,000
-9.3%
5,815
-29.1%
0.00%0.0%
Q2 2021$335,000
-1.8%
8,198
-23.6%
0.00%
-66.7%
Q4 2020$341,000
-70.1%
10,728
-75.9%
0.00%
-80.0%
Q3 2020$1,141,000
+513.4%
44,474
+266.5%
0.02%
+200.0%
Q1 2020$186,000
-83.1%
12,134
-91.8%
0.01%
-50.0%
Q3 2019$1,100,000
+58.3%
147,257
+175.0%
0.01%
+42.9%
Q2 2019$695,000
+44.2%
53,545
+35.3%
0.01%
+40.0%
Q1 2019$482,000
+66.8%
39,569
+56.0%
0.01%
+66.7%
Q4 2018$289,000
-45.8%
25,366
+3.3%
0.00%
-50.0%
Q3 2018$533,000
-25.5%
24,567
-39.3%
0.01%
-33.3%
Q2 2018$715,000
-25.2%
40,466
-10.9%
0.01%
-40.0%
Q1 2018$956,000
+267.7%
45,400
+175.1%
0.02%
+200.0%
Q3 2017$260,000
-15.0%
16,505
-18.6%
0.01%
-61.5%
Q4 2016$306,000
+84.3%
20,270
+86.6%
0.01%
+18.2%
Q3 2016$166,000
-56.0%
10,863
+55.2%
0.01%
-73.2%
Q4 2015$377,0007,0000.04%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 700,000$42,833,0008.57%
SILVERARC CAPITAL MANAGEMENT, LLC 308,819$18,897,0007.82%
Vahanian & Associates Financial Planning Inc. 45,533$2,786,0006.44%
DCF Advisers, LLC 238,500$14,594,0006.39%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 50,956$20,930,0004.72%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,531,923$93,738,0002.86%
Nicholas Investment Partners, LP 562,373$34,412,0002.45%
Bellevue Group AG 3,429,619$209,859,0002.44%
WASATCH ADVISORS LP 7,477,868$457,571,0002.25%
Quantum Private Wealth, LLC 73,772$4,514,0001.95%
View complete list of INTRA CELLULAR THERAPIES INC shareholders